Skip to main content
SpringerLink
Log in

Antianaerobic Activity of Grepafloxacin Compared with Ofloxacin, Ciprofloxacin, Clindamycin, Metronidazole and 5 β-Lactams

  • Poster Presentations
  • Extended Abstract
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard. 4th ed. NCCLS publication M11-A4. Villanova (PA): National Committee for Clinical Laboratory Standards, 1997

    Google Scholar 

  2. Goldstein EJC, Citron DM. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI960, CI 990 and WIN57273 against anaerobic bacteria. Antimicrob Agents Chemother 1992; 36: 1158–62

    Article  PubMed  CAS  Google Scholar 

  3. Wexler HM, Molitoris E, Reeves D, et al. In vitro activity of DU-6859a against anaerobic bacteria. Antimicrob Agents Chemother 1994; 38: 2504–9

    Article  PubMed  CAS  Google Scholar 

  4. Spangler SK, Jacobs MR, Appelbaum PC. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrob Agents Chemother 1994; 38: 2471–6

    Article  PubMed  CAS  Google Scholar 

  5. Citron D. Comparative in vitro activities of trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infections. Antimicrob Agents Chemother 1997; 41: 2312–6

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Microbiologie Clinique, Faculté de Pharmacie Lille, 3 rue Laguesse, BP83, 59006, Lille Cedex, France

    Luc Dubreuil, E. Singer & M. F. Odou

  2. Glaxo-Wellcome, Marly-le-Roi, France

    F. Leblanc

Authors
  1. Luc Dubreuil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Singer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. F. Odou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Leblanc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luc Dubreuil.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dubreuil, L., Singer, E., Odou, M.F. et al. Antianaerobic Activity of Grepafloxacin Compared with Ofloxacin, Ciprofloxacin, Clindamycin, Metronidazole and 5 β-Lactams. Drugs 58 (Suppl 2), 110–112 (1999). https://doi.org/10.2165/00003495-199958002-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199958002-00023

Search

Navigation